Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Mar 1;21(3):1104-1105.
doi: 10.4103/NRR.NRR-D-24-01465. Epub 2025 Mar 25.

Lysophosphatidic acid signaling: Transmembrane modulators in the central nervous system

Affiliations

Lysophosphatidic acid signaling: Transmembrane modulators in the central nervous system

Alexandra Polyzou et al. Neural Regen Res. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of regulators and effectors of LPA in the developing and adult central nervous system. (A) LPA species, abundance, and chaperones. (B–D) LPA synthesis and dephosphorylation. (E) Concentration range of LPA regulator/effector activities. (F–H) Plasma membrane LPA effectors including typical LPARs/GPCRs and atypical 6-TM membrane proteins. Values in panel E correspond to either Km values for enzymes ATX and PLPP1, or Kd values for LPARs, or EC50 values for functional assays (where applicable). For TRPs and PLPPRs the values are indicative based on functional assays (see text for details). CSF LPA levels are from Crack et al. (2014). Structures in B–D and F–H: ATX gamma in complex with LPA 18:1 (PDB ID: 8C3P); PLPP1 (AlphaFold, AF-O14494-F1); mPA-PLA1a/LIPH (AlphaFold, AF-Q8WWY8-F1); LPAR1 bound to LPA and Gi (PDB ID: 7TD0); ΤRPV1 full-length tetramer structure (PDB ID: 7LP9); PLPPR1 (AlphaFold, AF-Q8TBJ4-F1). CSF: Cerebrospinal fluid; LPA: lysophosphatidic acid; LPC: lysophosphatidylcholine; MAG: monoacylglycerol; PA: phosphatidic acid; T1/2: half-time; TM: transmembrane region.

References

    1. Benítez-Angeles M, Morales-Lázaro SL, Juárez-González E, Rosenbaum T. TRPV1: structure, endogenous agonists, and mechanisms. Int J Mol Sci. 2020;21:3421. - PMC - PubMed
    1. Benítez-Angeles M, Romero AEL, Llorente I, Hernández-Araiza I, Vergara-Jaque A, Real FH, Gutiérrez Castañeda ÓE, Arciniega M, Morales-Buenrostro LE, Torres-Quiroz F, García-Villegas R, Tovar-Y-Romo LB, Liedtke WB, Islas LD, Rosenbaum T. Modes of action of lysophospholipids as endogenous activators of the TRPV4 ion channel. J Physiol. 2023;601:1655–1673. - PubMed
    1. Cheng J, et al. Precise somatotopic thalamocortical axon guidance depends on LPA-mediated PRG-2/Radixin signaling. Neuron. 2016;92:126–142. - PMC - PubMed
    1. Crack PJ, Zhang M, Morganti-Kossmann MC, Morris AJ, Wojciak JM, Fleming JK, Karve I, Wright D, Sashindranath M, Goldshmit Y, Conquest A, Daglas M, Johnston LA, Medcalf RL, Sabbadini RA, Pébay A. Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes. J Neuroinflammation. 2014;11:37. - PMC - PubMed
    1. Fuchs J, Bareesel S, Kroon C, Polyzou A, Eickholt BJ, Leondaritis G. Plasma membrane phospholipid phosphatase-related proteins as pleiotropic regulators of neuron growth and excitability. Front Mol Neurosci. 2022;15:984655. - PMC - PubMed

LinkOut - more resources